Tender detail
Open house drug discount contracts for the active ingredient Filgrastim, ATC L03AA02
Summary
The tender concerns non-exclusive drug discount contracts for medicines with the active ingredient Filgrastim (ATC L03AA02) to be concluded during 01 November 2026 to 31 October 2028, with the possibility of contract award at any time under an open-house model. Medicines for pediatric use are excluded in accordance with the BfArM list.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.